What changed since the last analysis
The June/2026 management report closed out a transition the previous analysis had caught half-finished. Three concrete developments: the portfolio rotation was completed — the manager sold R$8,182,836 of units in credit-focused FIIs and bought two brand-new CRIs (Certificados de Recebíveis Imobiliários, Brazil's real-estate-backed securities) straight from its own origination book; the result per share eased from R$1.10 to R$1.07, still comfortably above the R$0.95 paid out, which pushed the accumulated accounting reserve up from R$0.64 to R$0.76/share; and the fund reached 18 consecutive months of R$0.95 DPS without moving a single cent. But the most important item isn't in the portfolio numbers — it's in the manager's macro read, and that's where we start.
The macro U-turn: HSI no longer sees a Selic cut
This is the point that reorders the entire thesis. The prior analysis treated dividend compression as a when, not an if: with the Selic heading toward 13.25%, the CDI-linked slice of the portfolio (the CDI, Brazil's interbank rate, tracks the Selic closely) would earn less and the R$0.95 would shrink within 12 to 18 months. The math was mechanical — every 1 percentage point of Selic decline compresses roughly R$0.03/share per month on the CDI+ leg.
Now the manager itself — which lives in the credit market and sees rate pass-through before the retail investor does — says those cuts aren't coming. If the Selic stays parked at 14.25%, the CDI stays parked with it, and the erosion that haunted the dividend simply doesn't happen over the projected horizon. For anyone holding the fund for income, that's the best possible news: the R$0.95 is more defensible than it was a month ago — not because the fund got stronger, but because the headwind stopped blowing.
There's a flip side, and glossing over it would be too easy. The reason the Selic isn't falling is that inflation remains under pressure — Brent crude above US$100 and a rising IGP (Brazil's wholesale price index) have pushed the IPCA higher. Roughly 40% of HSAF11's portfolio is indexed to the IPCA, so that same inflation improves the monetary correction on the IPCA+ leg (which, in fact, is what propped up June's stronger cash result). The good comes glued to the bad: high inflation is great for a price-indexed portfolio, but it's a symptom of a tighter economy, rising cost of living and a real interest rate that won't budge. The unitholder gains on the CRI's inflation adjustment what they lose in their wallet as a consumer.
The rotation, completed: two new CRIs replacing the FIIs
In June, HSI sold R$8,182,836 in units of other credit FIIs — trimming the fund-of-funds slice from 17.3% to 13.5% of assets — and put the money into two deals originated in-house:
| New CRI | % of NAV | Spread | Duration | LTV |
|---|---|---|---|---|
| Shopping Jaraguá do Sul (SC) | 5.3% | IPCA + 9.25% | 4.4 years | 62% |
| Yakã Residence (João Pessoa/PB) | 2.2% | CDI + 5.49% | 2.8 years | 66% |
The Shopping Jaraguá do Sul CRI (R$11.8M) has the mall of the same name — owned by Grupo Partage — as its debtor, securitized by HabitaSec. The collateral is solid: 1.39x debt-service coverage (the mall's cash flow covers the installment with a 39% cushion), fiduciary assignment of the property's receivables, a chattel mortgage on the building itself, and a guarantee from the controlling shareholders. The Yakã CRI (R$5.0M) funds the completion of the Yakã Residence Resort in João Pessoa, with Riza as securitizer — the project is about 40% built and 93% of the units already sold, which cuts the risk of unsold inventory. It's a construction CRI, so it carries a more development-heavy profile (execution risk) than the portfolio's stabilized cash-flow CRIs.
Why the result fell from R$1.10 to R$1.07
The R$0.03/share drop in the result isn't a sign of deterioration — it's the accounting signature of the rotation. Units of credit FIIs pay a full, net monthly dividend and trade on the exchange in minutes; they work like a cash parking lot that already drips income. The catch is that this income arrives with a layer of the target fund's fee in the middle and tracks the CDI more closely. By selling those FIIs, the fund gives up income that was already running. The two new CRIs, in exchange, carry full spread at origination — IPCA + 9.25% and CDI + 5.49%, with no intermediary fee — but take a few months to mature inside the result (mark-to-market, interest flow still incomplete in the entry month).
Add it all up: you swap smaller, ready-made income for larger income that still needs to fill out. In the short term the result eases a little — hence the R$1.07. Over the medium term, with both CRIs running at full spread, the trend reverses. It's not a loss of quality; it's the short-run cost of upgrading the portfolio. What matters for the unitholder is that, even with the step-back, the fund still generated R$0.12 more than it distributed — and that surplus became reserve.
LTV of 62% and 66%: the new CRIs are less armored than the old portfolio
Here's the caveat the report doesn't underline but the investor needs to see. A quick refresher on the acronym for those who aren't regulars: LTV is Loan-to-Value, the ratio between the amount lent and the value of the collateral. An LTV of 62% means the CRI represents 62% of what the collateral is worth — or, flipping it, the collateral would have to lose 38% of its value before the fund starts taking a loss. The lower the LTV, the thicker the collateral cushion.
The two new CRIs are far less conservative on collateral than the jewel of the historical portfolio. The Hotel Emiliano CRI — the fund's largest position, 13.7% of NAV — carries a 34% LTV, an almost exaggerated margin of safety: the collateral could melt two-thirds of its value and still cover the debt. The new ones come in at 62% and 66%, closer to what a bank lends on an ordinary mortgage (70% to 80%). These are still acceptable levels for granular CRIs backed by real collateral, but the unitholder is taking on a bit more collateral risk in exchange for fat spreads (9.25% and 5.49% over the indices). It's no cause for alarm — the extra guarantees (fiduciary assignment, controlling-shareholder guarantee, 1.39x coverage on Jaraguá) partly offset it — but it's honest to note that the rotation nudged the portfolio into a marginally tighter collateral tier. It's the kind of trade-off that shows up when a fund chases spread in a high-rate environment.
The cushion rose to R$0.76/share — and payout hit 89%
When a FII generates more cash than it pays, it builds a cushion of accumulated result. HSAF11 has been doing exactly that month after month: the balance went from R$0.64 to R$0.76/share, an addition of R$0.12 in June alone. The payout rose from 86% to 89% — meaning the fund distributed a slightly bigger slice than it generated, but still retained 11%, keeping the reserve build going. A payout below 100% with a stable DPS is exactly the portrait of a fund that makes cash.
Why does this matter more now? Because, even with the Selic projected flat, July guidance points to a result in the R$0.90 to R$1.00/share range. If in some month the result lands below R$0.95, management can top up the distribution from the reserve and hold the dividend, rather than passing the hiccup on to the unitholder. With R$0.76/share stored away, there's ammunition to weather several tight months without cutting the payout. It's a bumper, not an eternal guarantee — but in a flat-Selic scenario, the odds of needing to tap that cushion chronically have fallen.
July guidance: R$0.90 to R$1.00 — caution, not alarm
The manager flagged a July result between R$0.90 and R$1.00/share. Read without context, the low end (R$0.90) looks like a step down from the R$0.95 paid out. But the correct reading is different: the range brackets R$0.95 at its midpoint and reflects the still-incomplete maturation of the two new CRIs, not a credit deterioration. It's a slight downward bias on the result of one specific month, well within the normal historical variation of a paper fund — and even in the pessimistic case of a R$0.90 print, the R$0.76/share reserve covers the gap effortlessly. What you should not do is ignore the signal: it confirms that the rotation cost income in the very short term, exactly as the mechanics of the swap predicted.
The portfolio today: 21 CRIs, 100% performing, FIIs at 13.5%
After the rotation, the allocation looks like this:
| Class | % of NAV | Characteristic |
|---|---|---|
| IPCA+ CRIs | ~40% | average spread IPCA + 8.73% |
| CDI+ CRIs | ~32% | average spread CDI + 4.73% |
| Credit / Brick FIIs | 13.5% | KNIP11, KNCR11, MCCI11, KNSC11 and others |
| Fixed income / Cash | ~14% | ammunition for new deals |
The fund holds 21 CRIs spread across hospitality, residential, malls, education, tourism, healthcare and home equity, with 100% performing loans since the IPO in Sep/2020 — every CRI current on its financial obligations. The spreads remain robust: some deals pay IPCA+ in the 9% to nearly 11% range (Creditas at IPCA + 10.85%, Beach Park at IPCA + 9.75%), which sustains income even if the CDI+ leg doesn't grow. The portfolio's average duration runs around 3.9 years, a term consistent with the mandate.
The one sensitive credit spot remains the exposure to GPA, in out-of-court reorganization — a CRI worth just 0.4% of NAV, with a chattel mortgage on 13 properties (R$254M in collateral, which withstands a haircut of up to 31.5%), the immediate debtor being another FII and leases being honored. Low material risk, but honest to flag. Concentration in the four largest positions (Hotel Emiliano, Heritage, Itapê and Patrimônio IPCA) adds up to about 41% of NAV — the portfolio's most relevant structural weakness, protected by the conservative LTVs of the anchor deals.
P/BV 0.88 and fair value R$89.21: the discount that's left
With the unit at R$77.90 and book value at R$88.63/share, the P/BV stands at 0.88 — a 12.1% discount to book. In plain terms: you pay R$0.88 for every R$1.00 of book value in a portfolio that's 100% performing and marked to market. It's a bigger discount than a month ago (the unit slipped from R$79.80 to R$77.90 while book value barely moved), which makes the entry point marginally more attractive.
The model points to a fair value of R$89.21 (range R$84.75 to R$93.67), implying upside of around 14% just to close the discount to book value, before counting dividends. On the current price, the R$0.95 monthly payout works out to an annualized dividend yield near 14.6%. The combination — a double-digit discount to book, a 14%+ yield and now a flat-Selic scenario that reduces the risk of a dividend cut — is what underpins the buy thesis. One operational detail reinforces it: year-to-date secondary liquidity is close to R$1 million/day, high for a fund this size, which makes building and unwinding a position easy.
Verdict: the macro news improves the thesis
The macro U-turn works in the fund's favor. A month ago, the thesis's chief risk looked certain: a falling Selic would compress the dividend. Now HSI itself says the Selic stays parked at 14.25% through the end of 2026 — and, if it's right, that risk all but evaporates over the projected horizon. You enter with a 12.1% discount to book (P/BV 0.88, even cheaper than a month ago), a yield near 14.6%, 18 months of R$0.95 DPS and a cushion that grew to R$0.76/share. The result eased from R$1.10 to R$1.07 and July guidance carries a slight downward bias (R$0.90–1.00), but that's the short-run accounting cost of the rotation — the manager swapped liquid FIIs for two in-house CRIs with full spread (IPCA + 9.25% and CDI + 5.49%) that still have to mature. The real caveat: those two new CRIs carry LTVs of 62% and 66%, tighter collateral than the historical portfolio (Emiliano at 34%). With a fair value of R$89.21 (upside ~14% from re-rating alone) and 100% performing loans across nearly 6 years, the risk/reward stays favorable to the buyer. We keep the 8.0 — not out of inertia, but because the good macro news (less risk of a cut) offsets the neutral-to-negative operational side (weaker result and guidance).
